13 Einträge gefunden

1. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

   1. Heumann, Asmus
   2. Heinemann, Nina
   3. Hube-Magg, Claudia
   4. Lang, Dagmar S
   5. Grupp, Katharina
   6. Kluth, Martina
   7. Minner, Sarah

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
2. Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

   1. Burdelski, Christoph
   2. Kleinhans, Sandra
   3. Kluth, Martina
   4. Hube-Magg, Claudia
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2016 - Forschungsinformationssystem des UKE
3. Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

   1. Pust, Alexandra
   2. Kylies, Dominik
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Grob, Tobias

   2016 - Forschungsinformationssystem des UKE
4. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

   1. Melling, Nathaniel
   2. Taskin, B
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Grob, Tobias

   2016 - Forschungsinformationssystem des UKE
5. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

   1. Burdelski, Christoph
   2. Reiswich, V.
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
6. Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

   1. Grupp, Katharina
   2. Roettger, Laura
   3. Kluth, Martina
   4. Hube-Magg, Claudia
   5. Simon, Ronald
   6. Lebok, Patrick
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE
7. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

   1. Melling, Nathaniel
   2. Thomsen, Erik
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE
8. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

   1. Burdelski, Christoph
   2. Menan, Devi
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Melling, Nathaniel
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
9. High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

   1. Melling, Nathaniel
   2. Harutyunyan, Levon
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Lebok, Patrick
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
10. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

    1. Tsourlakis, Maria Christina
    2. Khosrawi, Puya
    3. Weigand, Philipp
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Minner, Sarah
    7. Koop, Christina

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
11. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

    1. Burdelski, Christoph
    2. Strauss, Christian
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Melling, Nathaniel
    7. Lebok, Patrick

    2015 - Forschungsinformationssystem des UKE
12. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

    1. Burdelski, Christoph
    2. Bujupi, Erzen
    3. Tsourlakis, Maria Christina
    4. Hube-Magg, Claudia
    5. Kluth, Martina
    6. Melling, Nathaniel
    7. Lebok, Patrick

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
13. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy

    1. Grupp, Katharina
    2. Höhne, Thorsten Simon
    3. Prien, Kristina
    4. Hube-Magg, Claudia
    5. Tsourlakis, Maria Christina
    6. Sirma, Hüseyin
    7. Pham, Taher

    2013 - Forschungsinformationssystem des UKE